JenniferRuthPyleMD

PubMed

• Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase.
  Chang, M.Y., Smith, C., Duhadaway, J.B., Pyle, J.R., Boulden, J., Peralta Soler, A., Muller, A.J., Laury-Kleintop, L.D., Prendergast, G.C.> ;Cancer Biol Ther. 2011 Dec 15
• 36 citations
  Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical...
  Roshani R. Patel, Surojeet Sengupta, Helen R. Kim, Andres J. Klein-Szanto, Jennifer R. Pyle, Fang Zhu, Tianyu Li, Eric A. Ross, Salewa Oseni, Joseph Fargnoli, V. Craig...> ;European Journal of Cancer. 2010 Jun 1
• 52 citations
  Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
  Joan S. Lewis-Wambi, Helen Kim, Chris Wambi, Roshani R. Patel, Jennifer R. Pyle, Andres J. Klein-Szanto, V. Craig Jordan> ;Breast Cancer Research. 2008 Dec 5
• 139 citations
  Selective estrogen receptor modulators and phytoestrogens.
  Tawakalitu Oseni, Roshani R. Patel, Jennifer R. Pyle, V. Craig Jordan> ;Planta Medica. 2008 Oct 1
• 47 citations
  Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
  Eric A. Ariazi, Andrei Leitão, Tudor I. Oprea, Bin Chen, Teresa E Louis, Anne M. Bertucci, Catherine G.N. Sharma, Shaun D. Gill, Helen Kim, Heather A. Shupp, Jennifer ...> ;Molecular Cancer Therapeutics. 2007 Nov 1
• 17 citations
  Emerging principles for the development of resistance to antihormonal therapy: Implications for the clinical utility of fulvestrant
  Eric A. Ariazi, Joan S. Lewis-Wambi, Shaun D. Gill, Jennifer R. Pyle, Jennifer L. Ariazi, Helen Kim, Catherine G.N. Sharma, Fernando Cordera, Heather A. Shupp, Tianyu ...> ;The Journal of Steroid Biochemistry and Molecular Biology. 2006 Dec 1
• Join now to see all